Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
| Molecular Weight | 793.0 g/mol |
|---|---|
| Molecular Formula | C38H68N2O13S |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 7 |
| Exact Mass | 792.44421140 g/mol |
| Monoisotopic Mass | 792.44421140 g/mol |
| Topological Polar Surface Area | 219 Ų |
| Heavy Atom Count | 54 |
| Formal Charge | 0 |
| Complexity | 1210 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 18 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Erythromycin Thiocyanate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Erythromycin Thiocyanate, including repackagers and relabelers. The FDA regulates Erythromycin Thiocyanate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Erythromycin Thiocyanate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Erythromycin Thiocyanate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Erythromycin Thiocyanate supplier is an individual or a company that provides Erythromycin Thiocyanate active pharmaceutical ingredient (API) or Erythromycin Thiocyanate finished formulations upon request. The Erythromycin Thiocyanate suppliers may include Erythromycin Thiocyanate API manufacturers, exporters, distributors and traders.
click here to find a list of Erythromycin Thiocyanate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Erythromycin Thiocyanate DMF (Drug Master File) is a document detailing the whole manufacturing process of Erythromycin Thiocyanate active pharmaceutical ingredient (API) in detail. Different forms of Erythromycin Thiocyanate DMFs exist exist since differing nations have different regulations, such as Erythromycin Thiocyanate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Erythromycin Thiocyanate DMF submitted to regulatory agencies in the US is known as a USDMF. Erythromycin Thiocyanate USDMF includes data on Erythromycin Thiocyanate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Erythromycin Thiocyanate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Erythromycin Thiocyanate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Erythromycin Thiocyanate Drug Master File in Japan (Erythromycin Thiocyanate JDMF) empowers Erythromycin Thiocyanate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Erythromycin Thiocyanate JDMF during the approval evaluation for pharmaceutical products. At the time of Erythromycin Thiocyanate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Erythromycin Thiocyanate suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Erythromycin Thiocyanate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Erythromycin Thiocyanate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Erythromycin Thiocyanate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Erythromycin Thiocyanate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Erythromycin Thiocyanate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Erythromycin Thiocyanate suppliers with NDC on PharmaCompass.
Erythromycin Thiocyanate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Erythromycin Thiocyanate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Erythromycin Thiocyanate GMP manufacturer or Erythromycin Thiocyanate GMP API supplier for your needs.
A Erythromycin Thiocyanate CoA (Certificate of Analysis) is a formal document that attests to Erythromycin Thiocyanate's compliance with Erythromycin Thiocyanate specifications and serves as a tool for batch-level quality control.
Erythromycin Thiocyanate CoA mostly includes findings from lab analyses of a specific batch. For each Erythromycin Thiocyanate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Erythromycin Thiocyanate may be tested according to a variety of international standards, such as European Pharmacopoeia (Erythromycin Thiocyanate EP), Erythromycin Thiocyanate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Erythromycin Thiocyanate USP).
LOOKING FOR A SUPPLIER?
